Robert Casey actually said...

We cannot allow this to continue as the status quo.

It is crucial that, during this reauthorization, we update our regulatory oversight and infrastructure at the FDA.

Thank you to the panelists for your remarks today.

Guaranteeing the safety and effectiveness of medical products is a task of paramount importance to the American public.